Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
MOG 0.390 +2.6% S 0.115 −25.8% OMI 0.305 −3.2% BMM 3.77 −0.8% CGD 0.630 +10.5% OCG 0.260 −7.1% CAMB 0.950 −5.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.00 −2.9% SGQ 0.400 +33.3% AMCO 0.225 −10.0% TRS 0.055 +0.0% RRI 0.260 −1.9% GAL 0.400 +0.0% LIB 0.780 −14.3% MOG 0.390 +2.6% S 0.115 −25.8% OMI 0.305 −3.2% BMM 3.77 −0.8% CGD 0.630 +10.5% OCG 0.260 −7.1% CAMB 0.950 −5.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.00 −2.9% SGQ 0.400 +33.3% AMCO 0.225 −10.0% TRS 0.055 +0.0% RRI 0.260 −1.9% GAL 0.400 +0.0% LIB 0.780 −14.3%

Healthcare

Page 43
  1. Mar 24, 2026 · 20:42 · XRTX

    XORTX Therapeutics shareholders approve 1:10 rollback

    XORTX Therapeutics shareholders approve 1:10 rollback

    01
  2. Mar 24, 2026 · 17:42 · AIDR

    Rocket Doctor AI expands California coverage

    Rocket Doctor AI expands California coverage

    02
  3. Mar 24, 2026 · 16:37 · VIVI

    Tempramed receives Chinese patent for Vivi Box

    Tempramed receives Chinese patent for Vivi Box

    03
  4. Mar 24, 2026 · 16:24 · SVA

    Sernova closes $2.1-million private placement

    Sernova closes $2.1-million private placement

    04
  5. Mar 24, 2026 · 12:28 · EDT

    Spectral, Vantive release Tigris results in Lancet

    Spectral, Vantive release Tigris results in Lancet

    05
  6. Mar 24, 2026 · 11:56 · BNXT

    Bionxt talks up global patent coverage for ODF

    Bionxt talks up global patent coverage for ODF

    06
  7. Mar 24, 2026 · 09:13 · ARCH

    Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial

    Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial

    07
  8. Mar 24, 2026 · 08:31 · APPT

    UberDoc Health Technologies Corp. Announces Listing on the Frankfurt Stock Exchange

    UberDoc Health Technologies Corp. Announces Listing on the Frankfurt Stock Exchange

    08
  9. Mar 24, 2026 · 08:00 · AIDR

    Rocket Doctor Expands California Coverage with New In-Network Agreement with a National Insurer, Adding Over 2 Million Members

    Rocket Doctor Expands California Coverage with New In-Network Agreement with a National Insurer, Adding Over 2 Million Members

    09
  10. Mar 24, 2026 · 07:01 · SVA

    Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing

    Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing

    10
  11. Mar 24, 2026 · 07:01 · VIVI

    TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box

    TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box

    11
  12. Mar 24, 2026 · 07:00 · FRX

    Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    12
  13. Mar 24, 2026 · 07:00 · EDT

    Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine

    Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine

    13
  14. Mar 24, 2026 · 05:10 · BNXT

    BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform

    BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform

    14
← Newer Older →